MedTrace Logo

Multi-site Evaluation of an Evidence-based Positive Youth Development Program

NCT02519530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8161

Last updated 2015-08-11

No results posted yet for this study

Summary

Investigators are carrying out a study to assess the immediate and long-term effects of a positive youth development program (the Teen Outreach Program) on high school youth in Florida. This study will answer the following questions: What is the impact of the Teen Outreach Program on sexual activity and positive youth development at the end of the program and 10 months after the program?

Conditions

  • Unintended Pregnancy
  • Adolescent Problem Behavior

Interventions

BEHAVIORAL

Teen Outreach Program

The Teen Outreach Program (TOP) is a positive youth development program that uses weekly educational peer group sessions, Community Service Learning (CSL), and positive adult guidance to help youth in grades 6-12 build healthy behaviors, life skills, and a sense of purpose. For this study, TOP was implemented in traditional public high schools in Florida and delivered by local health department staff, who were trained and certified as TOP facilitators. Youth enrolled in these classes received the TOP intervention in addition to, not as a replacement for, all business-as-usual curriculum content.

Sponsors & Collaborators

  • Florida Department of Health

    collaborator OTHER_GOV

  • The Office of Adolescent Health, HHS

    collaborator FED

  • University of South Florida

    lead OTHER

Principal Investigators

  • Ellen Daley, Ph.D · University of South Florida

  • Eric Buhi, Ph.D · San Diego State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-10-31
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02519530 on ClinicalTrials.gov